EGFR and small cell lung carcinoma: In addition, this discrepancy may reflect inherent biological differences in C-SCLC carcinogenesis, potentially involving alternative oncogenic pathways such as EGFR mutations or ALK rearrangements more prevalent in non-smokers and those with AC (23, 24).